Evidence map›Paper›PMID 21926393›Full record

ReviewProceedings of the American Thoracic Society2011

Cilia and models for studying structure and function.

Lawrence E Ostrowski, Susan K Dutcher, Cecilia W Lo

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Proceedings of the American Thoracic Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00450918 completednot on this map

Longitudinal Study of Primary Ciliary Dyskinesia: Participants 5-18 Years of Age

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2006 to 2019Enrolled150ConditionsPrimary Ciliary Dyskinesia
NCT00722878 completednot on this map

Early Onset and Progression of Primary Ciliary Dyskinesia Lung Disease Prior to 10 Years of Age

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2008 to 2019Enrolled48ConditionsKartagener Syndrome
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. microPublication biology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Review
  12. Article
  13. Article
  14. Acoustic Actuation ofJournal of micromechanics and microengineering : structures, devices, and systems · 2018
    Article
  15. Article
  16. Intraflagellar Transport and Ciliary Dynamics.Cold Spring Harbor perspectives in biology · 2017
    Review
  17. Mechanisms for nonmitotic activation of Aurora-A at cilia.Biochemical Society transactions · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Lawrence E OstrowskiDepartment of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. ostro@med.unc.edu
Susan K Dutcher
Cecilia W Lo
University of North Carolina at Chapel Hill · USUniversity of Pittsburgh · USWashington University in St. Louis · US

Funding

Modeling the genetic basis for human congenital heart disease in miceU01HL098180 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LO, CECILIA W. · 2009 to 2014
$8.5M
Pathogenesis of PCD Lung DiseaseR01HL071798 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KNOWLES, MICHAEL R · 2004 to 2021
$7.2M
GENETIC ANALYSIS OF BASAL BODY FUNCTIONR01GM032843 · NIGMS · WASHINGTON UNIVERSITY · PI DUTCHER, SUSAN K · 1985 to 2018
$5.9M
IDENTIFICATION OF BIOCHEMICAL ABNORMALITIES IN PCD CILIAR01HL063103 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI OSTROWSKI, LAWRENCE E · 1999 to 2002
$543k
Primary Ciliary Dyskinesia and Overlapping SyndromesR13HL105073 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVIS, STEPHANIE DUGGINS · 2010 to 2010
$15k
NHLBI NIH HHS HL063103NHLBI NIH HHS HL071798NHLBI NIH HHS HL105073NHLBI NIH HHS R01 HL071798NHLBI NIH HHS R13 HL105073NHLBI NIH HHS U01 HL098180NHLBI NIH HHS U01-HL098180NIGMS NIH HHS GM-032843NIGMS NIH HHS R01 GM032843
6 · The paper itself

Abstract

Because of the highly conserved nature of the ciliary axoneme, researchers studying the structure and function of cilia have used many different model systems. Each system has advantages and disadvantages, but all provide important information relevant to the understanding and treatment of the ciliopathies. For example, Chlamydomonas is easy to grow and amenable to rapid genetic manipulation and therefore is excellent for motility studies and studies of the structural components of the axoneme. However, this organism cannot be used to study developmental defects or physiological abnormalities that occur in higher organisms (e.g., mucociliary clearance). Human cilia have the advantage of being obtained directly from the tissue of interest but are obtainable only in limited quantities and are difficult to manipulate. Mouse models of ciliopathies are more difficult to study than Chlamydomonas but can be useful to elucidate more aspects of the human diseases. In this review, the overlap between the structure of primary and motile cilia is discussed, and recent advancements in our understanding of cilia structure and function using these three different model systems are presented. Potential therapeutic approaches, based on fundamental knowledge gained from work in these model systems, are also presented.

Indexed as

AnimalsAxonemeChlamydomonasCiliaDisease Models, AnimalFlagellaHeart Defects, CongenitalHeterotaxy SyndromeHumansKartagener SyndromeMiceModels, BiologicalMutationProteomeProteome

Identifiers

PMID21926393
PMCPMC3209580
OpenAlexW1973941080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.